info@synchemia.com | sales@synchemia.com 
9766925136 
Gefitinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gefitinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes, and did not receive cancer medicines in the past. Your doctor will perform a test before you take this medicine.Gefitinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gefitinib Nitroso CAS NO:NA chemically represented as N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Gefitinib Nitroso . We supply Gefitinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014451 |
| CAS No | NA |
| Mol.F. | C29H38ClN8O3P |
| Mol.Wt. | 613.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014452 |
| CAS No | NA |
| Mol.F. | C29H37ClN9O4P |
| Mol.Wt. | 642.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014453 |
| CAS No | NA |
| Mol.F. | C29H38ClN8O3P |
| Mol.Wt. | 613.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014454 |
| CAS No | NA |
| Mol.F. | C11H9BrN6O |
| Mol.Wt. | 321.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N014455 |
| CAS No | NA |
| Mol.F. | C4H4N4O3 |
| Mol.Wt. | 156.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014456 |
| CAS No | NA |
| Mol.F. | C4H4N4O3 |
| Mol.Wt. | 156.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014457 |
| CAS No | NA |
| Mol.F. | C3H2N4O3 |
| Mol.Wt. | 142.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014458 |
| CAS No | NA |
| Mol.F. | C3H2N4O3 |
| Mol.Wt. | 142.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014459 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014460 |
| CAS No | NA |
| Mol.F. | C6H7N3O3S |
| Mol.Wt. | 201.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014461 |
| CAS No | NA |
| Mol.F. | C19H18FN3O2 |
| Mol.Wt. | 339.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014462 |
| CAS No | NA |
| Mol.F. | C12H12N4O5S2 |
| Mol.Wt. | 356.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014463 |
| CAS No | NA |
| Mol.F. | C14H17N7O2 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014464 |
| CAS No | 28698-93-3 |
| Mol.F. | C22H24N4O8 |
| Mol.Wt. | 472.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014465 |
| CAS No | NA |
| Mol.F. | C13H14N2O4 |
| Mol.Wt. | 262.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014466 |
| CAS No | NA |
| Mol.F. | C11H9BrN6O |
| Mol.Wt. | 321.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
